Europe - EMA - European Medicines Agency
Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018
Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13
Europe -DG Health and Food Safety
Registration is free.
myHealthbox can improve the online visibility of your products by as much as 20%.
Contact us to find out more.
myHealthbox™ is a leading provider of health information services to consumers and healthcare professionals.